Company / SG&A Expense
Organogenesis Holdings Inc. SG&A Expense History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$269.8M
FY2025
5-year range
$200.1M / $283.8M
FY2021-FY2025
Trend
-5.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $250M to $270M over the past 2 years.
Based on SEC 10-K filings.
$270M in FY2025 with a 5-year CAGR of +10.7%.
Increased from $250M to $270M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +9.7%
- 5-Year CAGR
- +10.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +10.7%, indicating consistent growth.
- In FY2025, sg&a expense decreased 5.0% year-over-year.
- Peak sg&a expense was recorded in FY2024.
- Lowest sg&a expense in the period was in FY2018.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $269.8M | -5.0% |
| FY2024 | $283.8M | +13.4% |
| FY2023 | $250.2M | +22.5% |
| FY2022 | $204.2M | +2.1% |
| FY2021 | $200.1M | +23.5% |
| FY2020 | $162.0M | +21.1% |
| FY2019 | $133.7M | +43.7% |
| FY2018 | $93.0M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026